Rituximab Therapy for Focal Segmental Glomerulosclerosis and Minimal Change Disease in Adults: A Systematic Review and Meta-Analysis
BMC Nephrology - United Kingdom
doi 10.1186/s12882-020-01797-7
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 15, 2020
Authors
Publisher
Springer Science and Business Media LLC